216 related articles for article (PubMed ID: 20599558)
21. Subcellular localization and mechanisms of nucleocytoplasmic distribution of p202, an interferon-inducible candidate for lupus susceptibility.
Choubey D; Pramanik R; Xin H
FEBS Lett; 2003 Oct; 553(3):245-9. PubMed ID: 14572632
[TBL] [Abstract][Full Text] [Related]
22. Retinoblastoma (Rb) protein upregulates expression of the Ifi202 gene encoding an interferon-inducible negative regulator of cell growth.
Xin H; Pramanik R; Choubey D
Oncogene; 2003 Jul; 22(31):4775-85. PubMed ID: 12894219
[TBL] [Abstract][Full Text] [Related]
23. WDFY4 Is Involved in Symptoms of Systemic Lupus Erythematosus by Modulating B Cell Fate via Noncanonical Autophagy.
Yuan Q; Li Y; Li J; Bian X; Long F; Duan R; Ma X; Gao F; Gao S; Wei S; Li X; Sun W; Liu Q
J Immunol; 2018 Nov; 201(9):2570-2578. PubMed ID: 30257884
[TBL] [Abstract][Full Text] [Related]
24. Expression of an IFN-inducible cellular senescence gene, IFI16, is up-regulated by p53.
Song LL; Alimirah F; Panchanathan R; Xin H; Choubey D
Mol Cancer Res; 2008 Nov; 6(11):1732-41. PubMed ID: 18974396
[TBL] [Abstract][Full Text] [Related]
25. p202, an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition.
Datta B; Li B; Choubey D; Nallur G; Lengyel P
J Biol Chem; 1996 Nov; 271(44):27544-55. PubMed ID: 8910340
[TBL] [Abstract][Full Text] [Related]
26. The proapoptotic activity of the Interferon-inducible gene IFI16 provides new insights into its etiopathogenetic role in autoimmunity.
Gugliesi F; De Andrea M; Mondini M; Cappello P; Giovarelli M; Shoenfeld Y; Meroni P; Gariglio M; Landolfo S
J Autoimmun; 2010 Sep; 35(2):114-23. PubMed ID: 20488664
[TBL] [Abstract][Full Text] [Related]
27. Gender differences of B cell signature related to estrogen-induced IFI44L/BAFF in systemic lupus erythematosus.
Fan H; Zhao G; Ren D; Liu F; Dong G; Hou Y
Immunol Lett; 2017 Jan; 181():71-78. PubMed ID: 27923569
[TBL] [Abstract][Full Text] [Related]
28. Protein kinase cδ deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation.
Belot A; Kasher PR; Trotter EW; Foray AP; Debaud AL; Rice GI; Szynkiewicz M; Zabot MT; Rouvet I; Bhaskar SS; Daly SB; Dickerson JE; Mayer J; O'Sullivan J; Juillard L; Urquhart JE; Fawdar S; Marusiak AA; Stephenson N; Waszkowycz B; W Beresford M; Biesecker LG; C M Black G; René C; Eliaou JF; Fabien N; Ranchin B; Cochat P; Gaffney PM; Rozenberg F; Lebon P; Malcus C; Crow YJ; Brognard J; Bonnefoy N
Arthritis Rheum; 2013 Aug; 65(8):2161-71. PubMed ID: 23666743
[TBL] [Abstract][Full Text] [Related]
29. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus.
Rozzo SJ; Allard JD; Choubey D; Vyse TJ; Izui S; Peltz G; Kotzin BL
Immunity; 2001 Sep; 15(3):435-43. PubMed ID: 11567633
[TBL] [Abstract][Full Text] [Related]
30. TSPAN33 is a novel marker of activated and malignant B cells.
Luu VP; Hevezi P; Vences-Catalan F; Maravillas-Montero JL; White CA; Casali P; Llorente L; Jakez-Ocampo J; Lima G; Vilches-Cisneros N; Flores-Gutiérrez JP; Santos-Argumedo L; Zlotnik A
Clin Immunol; 2013 Dec; 149(3):388-99. PubMed ID: 24211713
[TBL] [Abstract][Full Text] [Related]
31. Systemic lupus erythematosus and B-cell hematologic neoplasm.
Xu Y; Wiernik PH
Lupus; 2001; 10(12):841-50. PubMed ID: 11787873
[TBL] [Abstract][Full Text] [Related]
32. Absent in Melanoma 2 proteins in SLE.
Choubey D; Panchanathan R
Clin Immunol; 2017 Mar; 176():42-48. PubMed ID: 28062222
[TBL] [Abstract][Full Text] [Related]
33. IFI16, an amplifier of DNA-damage response: Role in cellular senescence and aging-associated inflammatory diseases.
Choubey D; Panchanathan R
Ageing Res Rev; 2016 Jul; 28():27-36. PubMed ID: 27063514
[TBL] [Abstract][Full Text] [Related]
34. [Interleukin-2 signaling pathway regulating molecules in systemic lupus erythematosus].
Guo Q; Chen XY; Su Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1100-1104. PubMed ID: 27987522
[TBL] [Abstract][Full Text] [Related]
35. Comment on: The candidate lupus susceptibility gene Ifi202a is largely dispensable for B-cell function.
Choubey D
Rheumatology (Oxford); 2008 Apr; 47(4):558-9; author reply 559. PubMed ID: 18272531
[No Abstract] [Full Text] [Related]
36. Hodgkin's lymphoma in systemic lupus erythematosus.
Bernatsky S; Ramsey-Goldman R; Isenberg D; Rahman A; Dooley MA; Sibley J; Boivin JF; Joseph L; Armitage J; Zoma A; Clarke A
Rheumatology (Oxford); 2007 May; 46(5):830-2. PubMed ID: 17255135
[TBL] [Abstract][Full Text] [Related]
37. Expression profile of HIN200 in leukocytes and renal biopsy of SLE patients by real-time RT-PCR.
Kimkong I; Avihingsanon Y; Hirankarn N
Lupus; 2009 Oct; 18(12):1066-72. PubMed ID: 19762380
[TBL] [Abstract][Full Text] [Related]
38. Interferon-α induces altered transitional B cell signaling and function in Systemic Lupus Erythematosus.
Chang NH; Li TT; Kim JJ; Landolt-Marticorena C; Fortin PR; Gladman DD; Urowitz MB; Wither JE
J Autoimmun; 2015 Apr; 58():100-10. PubMed ID: 25678471
[TBL] [Abstract][Full Text] [Related]
39. Increase of MZB1 in B cells in systemic lupus erythematosus: proteomic analysis of biopsied lymph nodes.
Miyagawa-Hayashino A; Yoshifuji H; Kitagori K; Ito S; Oku T; Hirayama Y; Salah A; Nakajima T; Kiso K; Yamada N; Haga H; Tsuruyama T
Arthritis Res Ther; 2018 Jan; 20(1):13. PubMed ID: 29382365
[TBL] [Abstract][Full Text] [Related]
40. Interferon (IFN)-inducible Absent in Melanoma 2 proteins in the negative regulation of the type I IFN response: Implications for lupus nephritis.
Choubey D; Panchanathan R
Cytokine; 2020 Aug; 132():154682. PubMed ID: 30904426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
